Michele Donato

Michele Donato

Auto-generated profile, based on publicly available information

Michele Donato

Stanford University School of Medicine

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2022 in Nature Immunology
Verified
Journal Article
Open access
PDF file
EMErin F. McCaffrey
Erin F. McCaffrey
MDMichele Donato
Michele Donato
LKLeeat Keren
Leeat Keren
ZCZhenghao Chen
Zhenghao Chen
ADAlea Delmastro
Alea Delmastro
MAMichael Angelo
Michael Angelo
Tuberculosis (TB) in humans is characterized by formation of immune-rich granulomas in infected tissues, the architecture and composition of which are thought to affect disease outcome. However, our understanding of the spatial relationships that control human granulomas is limited. Here, we used multiplexed ion beam imaging by time of flight (MIBI-TOF) to image 37 proteins in tissues from patients with active TB. We constructed a comprehensive atlas that maps 19 cell subsets across 8 spatial microenvironments. This atlas shows an IFN-γ-depleted microenvironment enriched for TGF-β, regulatory T cells and IDO1+ PD-L1+ myeloid cells. In a further transcriptomic meta-analysis of peripheral blood from patients with TB, immunoregulatory trends mirror those identified by granuloma imaging. Notably, PD-L1 expression is associated with progression to active TB and treatment response. These data indicate that in TB granulomas, there are local spatially coordinated immunoregulatory programs with systemic manifestations that define active TB.

20 May 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
PCPeggie Cheung
Peggie Cheung
SSSteven Schaffert
Steven Schaffert
SCSarah E. Chang
Sarah E. Chang
MDMai Dvorak
Mai Dvorak
MDMichele Donato
Michele Donato
AKAlex J. Kuo
Alex J. Kuo

25 January 2023 in Science Translational Medicine
Verified
Journal Article
Closed access
MTMaureen Ty
Maureen Ty
SSShenghuan Sun
Shenghuan Sun
PCPerri C. Callaway
Perri C. Callaway
JRJohn Rek
John Rek
KPKathleen D. Press
Kathleen D. Press
PJPrasanna Jagannathan
Prasanna Jagannathan
Natural killer (NK) cells likely play an important role in immunity to malaria, but the effect of repeated malaria on NK cell responses remains unclear. Here, we comprehensively profiled the NK cell response in a cohort of 264 Ugandan children. Repeated malaria exposure was associated with expansion of an atypical, CD56 neg population of NK cells that differed transcriptionally, epigenetically, and phenotypically from CD56 dim NK cells, including decreased expression of PLZF and the Fc receptor γ-chain, increased histone methylation, and increased protein expression of LAG-3, KIR, and LILRB1. CD56 neg NK cells were highly functional and displayed greater antibody-dependent cellular cytotoxicity than CD56 dim NK cells. Higher frequencies of CD56 neg NK cells were associated with protection against symptomatic malaria and high parasite densities. After marked reductions in malaria transmission, frequencies of these cells rapidly declined, suggesting that continuous exposure to Plasmodium falciparum is required to maintain this modified, adaptive-like NK cell subset.

5 May 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
MGMingxia Gu
Mingxia Gu
MDMichele Donato
Michele Donato
MGMinzhe Guo
Minzhe Guo
NWNeil Wary
Neil Wary
YMYifei Miao
Yifei Miao
MRMarlene Rabinovitch
Marlene Rabinovitch
Drug screening for improved function and transcriptomics of iPSC-derived endothelial cells from patients with pulmonary hypertension reveals AG1296.

25 January 2018 in JCI Insight
Verified
Journal Article
Open access
PDF file
TATej D. Azad
Tej D. Azad
MDMichele Donato
Michele Donato
LHLine Heylen
Line Heylen
ALAndrew B. Liu
Andrew B. Liu
SSShai S Shen-Orr
Shai S Shen-Orr
PKPurvesh Khatri
Purvesh Khatri
Late allograft failure is characterized by cumulative subclinical insults manifesting over many years. Although immunomodulatory therapies targeting host T cells have improved short-term survival rates, rates of chronic allograft loss remain high. We hypothesized that other immune cell types may drive subclinical injury, ultimately leading to graft failure. We collected whole-genome transcriptome profiles from 15 independent cohorts composed of 1,697 biopsy samples to assess the association of an inflammatory macrophage polarization–specific gene signature with subclinical injury. We applied penalized regression to a subset of the data sets and identified a 3-gene inflammatory macrophage–derived signature. We validated discriminatory power of the 3-gene signature in 3 independent renal transplant data sets with mean AUC of 0.91. In a longitudinal cohort, the 3-gene signature strongly correlated with extent of injury and accurately predicted progression of subclinical injury 18 months before clinical manifestation. The 3-gene signature also stratified patients at high risk of graft failure as soon as 15 days after biopsy. We found that the 3-gene signature also distinguished acute rejection (AR) accurately in 3 heart transplant data sets but not in lung transplant. Overall, we identified a parsimonious signature capable of diagnosing AR, recognizing subclinical injury, and risk-stratifying renal transplant patients. Our results strongly suggest that inflammatory macrophages may be a viable therapeutic target to improve long-term outcomes for organ transplantation patients.

14 December 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MYMinyoung Youn
Minyoung Youn
SSStephanie M. Smith
Stephanie M. Smith
Alex LeeAlex Lee
Alex Lee
HCHee-Don Chae
Hee-Don Chae
ESElizabeth Spiteri
Elizabeth Spiteri
Kathleen SakamotoKathleen Sakamoto
Kathleen Sakamoto
Children with chronic myeloid leukemia (CML) tend to present with higher white blood counts and larger spleens than adults with CML, suggesting that the biology of pediatric and adult CML may differ. To investigate whether pediatric and adult CML have unique molecular characteristics, we studied the transcriptomic signature of pediatric and adult CML CD34+ cells and healthy pediatric and adult CD34+ control cells. Using high-throughput RNA sequencing, we found 567 genes (207 up- and 360 downregulated) differentially expressed in pediatric CML CD34+ cells compared to pediatric healthy CD34+ cells. Directly comparing pediatric and adult CML CD34+ cells, 398 genes (258 up- and 140 downregulated), including many in the Rho pathway, were differentially expressed in pediatric CML CD34+ cells. Using RT-qPCR to verify differentially expressed genes, VAV2 and ARHGAP27 were significantly upregulated in adult CML CD34+ cells compared to pediatric CML CD34+ cells. NCF1, CYBB, and S100A8 were upregulated in adult CML CD34+ cells but not in pediatric CML CD34+ cells, compared to healthy controls. In contrast, DLC1 was significantly upregulated in pediatric CML CD34+ cells but not in adult CML CD34+ cells, compared to healthy controls. These results demonstrate unique molecular characteristics of pediatric CML, such as dysregulation of the Rho pathway, which may contribute to clinical differences between pediatric and adult patients.